Heron Therapeutics, Inc.
HRTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000818033
No open-market purchases or sales by Heron Therapeutics, Inc. insiders were filed in the last 90 days; 163 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Heron Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 162 | 149 | −13 |
| Shares | 107.9M | 98.8M | −9.10M (−8.4%) |
| Value | $163.1M | $114.7M | −$48.3M (−29.6%) |
New holders (16)
Institutions that held Heron Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| JW Asset Management, LLC | 2,207,418 | $2.56M | 0.93% |
| Jefferies Financial Group Inc. | 1,290,924 | $1.50M | 0.03% |
| Adage Capital Partners GP, L.L.C. | 1,000,000 | $1.16M | 0.00% |
| Monaco Asset Management SAM | 405,000 | $469.8K | 0.25% |
| Mutual of America Capital Management LLC | 221,650 | $257.1K | 0.00% |
| Point72 Middle East FZE | 67,821 | $78.7K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 66,326 | $76.9K | 0.01% |
| Richmond Brothers, Inc. | 42,405 | $49.2K | 0.08% |
| Raymond James Financial Services Advisors, Inc. | 32,950 | $38.2K | 0.00% |
| State of Wyoming | 24,024 | $27.9K | 0.01% |
| Engineers Gate Manager LP | 17,648 | $20.5K | 0.00% |
| Estate Counselors, LLC | 17,000 | $19.7K | 0.00% |
| Headlands Technologies LLC | 2,643 | $3.07K | 0.00% |
| Bollard Group LLC | 956 | $1.00K | 0.00% |
| Farther Finance Advisors, LLC | 100 | $116 | 0.00% |
| Sofos Investments, Inc. | 1 | – | – |
Sold out (29)
Institutions that held Heron Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.